Skip to main content

Inoviq Ltd. Health Care
Cancer Healthcare Medical North America

$0.850 0.030 (3.66%)

High

$0.99

Low

$0.84

Trades

317

Turnover

$865,876

Volume

942,590
30 June 2023 at 4:10pm
If you were already registered, log in here.

Short Interest

ASIC data, 27 Oct 2026

% Shorted

0.00%
vs 0.00% prior report

Most Shorted Rank

696th
of 720 shorted ASX stocks

Peak Short

0.58%
Oct 2025

Days to Cover

0.0
at 50d avg vol
View full short position history →
Subject
StockBot
IIQ Ann: Notification of cessation of securities - IIQ

StockBot
IIQ Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation

StockBot
IIQ Ann: INOVIQ Investor Briefing

StockBot
IIQ Ann: Excellent Clinical Data for SubB2M/CA15-3 Breast Cancer Test

StockBot
IIQ Ann: ISEV Meeting Presentations

StockBot
IIQ Ann: Appendix 4C and Quarterly Activities Report - March 2023

StockBot
IIQ Ann: INOVIQ to present new EXO-NET data at ISEV Annual Meeting

StockBot
IIQ Ann: Change of Director's Interest Notice - Philip Powell

StockBot
IIQ Ann: Change of Director's Interest Notice - Philip Powell

StockBot
IIQ Ann: Appendix 4D and Half Year Financial Report

StockBot
IIQ Ann: Positive results for SubB2M Breast Cancer Test

StockBot
IIQ Ann: Notification regarding unquoted securities - IIQ

StockBot
IIQ Ann: Notification of cessation of securities - IIQ

StockBot
IIQ Ann: Appendix 4C & Quarterly Activities Report - December 2022

StockBot
IIQ Ann: Final Director's Interest Notice

StockBot
IIQ Ann: Resignation of Director

StockBot
IIQ Ann: Positive EXO-NET Results in Ovarian Cancer

StockBot
IIQ Ann: MST Access Diagnostics Forum Presentation

StockBot
IIQ Ann: Change in substantial holding

StockBot
IIQ Ann: Results of 2022 Annual General Meeting

StockBot
IIQ Ann: CEO AGM Presentation

StockBot
IIQ Ann: INOVIQ Settles Legal Proceedings

StockBot
IIQ Ann: Commercial and R&D Update

StockBot
IIQ Ann: Healthcare Conference Investor Presentation

StockBot
IIQ Ann: Appendix 4C - Statement pursuant to Listing Rule 4.7C.3

StockBot
IIQ Ann: IIQ Appendix 4C & Quarterly Activities Report-September 2022

StockBot
IIQ Ann: Canadian Patent Granted for BARD1 Technology

StockBot
IIQ Ann: Investor Presentation

StockBot
IIQ Ann: Notice of Annual General Meeting

StockBot
IIQ Ann: Receipt of R&D Tax Incentive Refund

StockBot
IIQ Ann: INOVIQ to Develop SubB2M-Based Test on Nicoya SPR Platform

StockBot
IIQ Ann: Appendix 4G and Corporate Governance Statement

StockBot
IIQ Ann: Appointment/Resignation of CFO and Company Secretary

StockBot
IIQ Ann: Notification of cessation of securities - IIQ

StockBot
IIQ Ann: Notice required under listing rule 3.13.1

StockBot
IIQ Ann: 2022 Annual Report and update on results

StockBot
IIQ Ann: Appendix 4E and Preliminary Financial Report

StockBot
IIQ Ann: IIQ Investor Presentation

StockBot
IIQ Ann: INOVIQ Investor Briefing Invitation - June 2022 Quarter

StockBot
IIQ Ann: IIQ Appendix 4C & Quarterly Activities Report - June 2022

StockBot
IIQ Ann: Positive SubB2M IHC Results for Melanoma

StockBot
IIQ Ann: hTERT US Patent Granted

StockBot
IIQ Ann: INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out

StockBot
IIQ Ann: SubB2M US Patent Grant and Program Update

StockBot
IIQ Ann: INOVIQ&University of Sydney Present New EXO-NET Data at ISEV

StockBot
IIQ Ann: Change of Director's Interest - Philip Powell

StockBot
IIQ Ann: IIQ Investor Presentation

StockBot
IIQ Ann: Change of Director's Interest - Dr Geoffrey Cumming

StockBot
IIQ Ann: Change of Director's Interest - Philip Powell

StockBot
IIQ Ann: INOVIQ Investor Briefing Invitation

If you were already registered, log in here.

Upcoming Floats (6)

SUPER MINERALS LTD
S88
CAPABILITY X LIMITED
CX8
MAVERICK URANIUM LIMITED
MAV $7.5m raise
MATRIX CRITICAL MINERALS LIMITED
MTX $12m raise
RIO DE ORO CORP LTD
RDO $30m raise
Gratifii
MBM
Top